1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity. (9th November 2020) Authors: Bol, Kees; Marissen, Wilfred; Elaissais-Schaap, Jeroen; Tacken, Paul; Engels, Steef; Wang, Liang-Chuan; Mondal, Arpita; Throsby, Mark; Roberts, Alan; Mayes, Patrick; Geuijen, Cecile Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A863 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity. (9th November 2020) Authors: Bol, Kees; Marissen, Wilfred; Elaissais-Schaap, Jeroen; Tacken, Paul; Engels, Steef; Wang, Liang-Chuan; Mondal, Arpita; Throsby, Mark; Roberts, Alan; Mayes, Patrick; Geuijen, Cecile Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A487 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 820 MCLA-145 is a bispecific IgG1 antibody that inhibits PD-1/PD-L1 signaling while simultaneously activating CD137 signaling on T cells. (9th November 2020) Authors: Tacken, Paul; Wang, Liang-chuan; Klooster, Rinse; Loo, Pieter Fokko Van; Zhou, Jing; Mondal, Arpita; Liu, Yao-Bin; Kramer, Arjen; Condamine, Thomas; Volgina, Alla; Hendriks, Linda; Maaden, Hans van der; Rovers, Eric; Engels, Steef; Fransen, Floris; Blanken-Smit, Renate den; Zande, Vanessa Zondag-... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 820 MCLA-145 is a bispecific IgG1 antibody that inhibits PD-1/PD-L1 signaling while simultaneously activating CD137 signaling on T cells. (9th November 2020) Authors: Tacken, Paul; Wang, Liang-chuan; Klooster, Rinse; Loo, Pieter Fokko Van; Zhou, Jing; Mondal, Arpita; Liu, Yao-Bin; Kramer, Arjen; Condamine, Thomas; Volgina, Alla; Hendriks, Linda; Maaden, Hans van der; Rovers, Eric; Engels, Steef; Fransen, Floris; Blanken-Smit, Renate den; Zande, Vanessa Zondag-... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A870 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development. (April 2007) Authors: Throsby, Mark; ter Meulen, Jan; Geuijen, Cecile; Goudsmit, Jaap; de Kruif, John Journal: Expert review of vaccines Issue: Volume 6:Number 2(2007) Page Start: 183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. MCLA-117, a CLEC12AxCD3 bispecific antibody targeting a leukaemic stem cell antigen, induces T cell-mediated AML blast lysis. (3rd July 2019) Authors: van Loo, Pieter Fokko; Hangalapura, Basav N.; Thordardottir, Soley; Gibbins, John D.; Veninga, Henrike; Hendriks, Linda J. A.; Kramer, Arjen; Roovers, Rob C.; Leenders, Marij; de Kruif, John; Doornbos, Robert P.; Sirulnik, Andres; Throsby, Mark; Logtenberg, Ton; Dolstra, Harry; Bakker, Alexander ... Journal: Expert opinion on biological therapy Issue: Volume 19:Number 7(2019) Page Start: 721 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗